XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2021 $ (23,809)   $ 2 $ 1,054   $ (24,865)
Beginning Balance of Temporary Equity, Shares at Dec. 31, 2021   27,471,911        
Beginning Balance of Temporary Equity, Value at Dec. 31, 2021   $ 122,518        
Beginning Balance, Shares at Dec. 31, 2021     1,769,561      
Stock-based compensation expense 40     40    
Net loss (7,220)         (7,220)
Ending Balance at Mar. 31, 2022 (30,989)   $ 2 1,094   (32,085)
Ending Balance of Temporary Equity, Shares at Mar. 31, 2022   27,471,911        
Ending Balance of Temporary Equity, Value at Mar. 31, 2022   $ 122,518        
Ending Balance, Shares at Mar. 31, 2022     1,769,561      
Beginning Balance at Dec. 31, 2021 (23,809)   $ 2 1,054   (24,865)
Beginning Balance of Temporary Equity, Shares at Dec. 31, 2021   27,471,911        
Beginning Balance of Temporary Equity, Value at Dec. 31, 2021   $ 122,518        
Beginning Balance, Shares at Dec. 31, 2021     1,769,561      
Unrealized gain (loss) on available-for-sale investments, net of tax (133)          
Net loss (22,238)          
Ending Balance at Sep. 30, 2022 (45,616)   $ 2 1,618 $ (133) (47,103)
Ending Balance of Temporary Equity, Shares at Sep. 30, 2022   27,471,911        
Ending Balance of Temporary Equity, Value at Sep. 30, 2022   $ 122,518        
Ending Balance, Shares at Sep. 30, 2022     1,794,600      
Beginning Balance at Mar. 31, 2022 (30,989)   $ 2 1,094   (32,085)
Beginning Balance of Temporary Equity, Shares at Mar. 31, 2022   27,471,911        
Beginning Balance of Temporary Equity, Value at Mar. 31, 2022   $ 122,518        
Beginning Balance, Shares at Mar. 31, 2022     1,769,561      
Stock-based compensation expense 233     233    
Net loss (5,820)         (5,820)
Ending Balance at Jun. 30, 2022 (36,576)   $ 2 1,327   (37,905)
Ending Balance of Temporary Equity, Shares at Jun. 30, 2022   27,471,911        
Ending Balance of Temporary Equity, Value at Jun. 30, 2022   $ 122,518        
Ending Balance, Shares at Jun. 30, 2022     1,769,561      
Exercise of common stock options 24     24    
Exercise of common stock options, Shares     25,039      
Stock-based compensation expense 267     267    
Unrealized gain (loss) on available-for-sale investments, net of tax (133)       (133)  
Net loss (9,198)         (9,198)
Ending Balance at Sep. 30, 2022 (45,616)   $ 2 1,618 (133) (47,103)
Ending Balance of Temporary Equity, Shares at Sep. 30, 2022   27,471,911        
Ending Balance of Temporary Equity, Value at Sep. 30, 2022   $ 122,518        
Ending Balance, Shares at Sep. 30, 2022     1,794,600      
Beginning Balance at Dec. 31, 2022 170,475   $ 22 226,580 (95) (56,032)
Beginning Balance, Shares at Dec. 31, 2022     21,920,402      
Exercise of common stock options, Shares     232      
Stock-based compensation expense 2,646     2,646    
Unrealized gain (loss) on available-for-sale investments, net of tax 104       104  
Net loss (12,756)         (12,756)
Ending Balance at Mar. 31, 2023 160,469   $ 22 229,226 9 (68,788)
Ending Balance, Shares at Mar. 31, 2023     21,920,634      
Beginning Balance at Dec. 31, 2022 $ 170,475   $ 22 226,580 (95) (56,032)
Beginning Balance, Shares at Dec. 31, 2022     21,920,402      
Exercise of common stock options, Shares 183,927          
Unrealized gain (loss) on available-for-sale investments, net of tax $ (207)          
Net loss (41,136)          
Ending Balance at Sep. 30, 2023 138,149   $ 22 235,597 (302) (97,168)
Ending Balance, Shares at Sep. 30, 2023     22,104,469      
Beginning Balance at Mar. 31, 2023 160,469   $ 22 229,226 9 (68,788)
Beginning Balance, Shares at Mar. 31, 2023     21,920,634      
Exercise of common stock options 379     379    
Exercise of common stock options, Shares     148,026      
Stock-based compensation expense 2,686     2,686    
Unrealized gain (loss) on available-for-sale investments, net of tax (436)       (436)  
Net loss (13,914)         (13,914)
Ending Balance at Jun. 30, 2023 149,184   $ 22 232,291 (427) (82,702)
Ending Balance, Shares at Jun. 30, 2023     22,068,660      
Exercise of common stock options 78     78    
Exercise of common stock options, Shares     35,669      
Issuance of common stock upon vesting of restricted stock units, Shares     140      
Stock-based compensation expense 3,228     3,228    
Unrealized gain (loss) on available-for-sale investments, net of tax 125       125  
Net loss (14,466)         (14,466)
Ending Balance at Sep. 30, 2023 $ 138,149   $ 22 $ 235,597 $ (302) $ (97,168)
Ending Balance, Shares at Sep. 30, 2023     22,104,469